ITMCTR2000003696尚未招募1 期
A randomized, double-blind, placebo-controlled clinical trial of Huaizhen Yanggan capsule in the treatment of knee osteoarthritis
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 40 至 70（—）
- 性别
- All
入选标准
- •(1) Patients with knee osteoarthritis who meet the diagnostic criteria of Western medicine and TCM syndrome differentiation;
- •(2) Aged 40-70 years old male and female;
- •(3) KL grade was 0-3;
- •(4) VAS score >=4;
- •(5) The subjects had informed consent and signed the informed consent voluntarily.
排除标准
- •(1) KL grade 4;
- •(2) Other inflammatory and painful diseases of knee joint, such as rheumatoid arthritis, psoriatic arthritis, gout, tumor, joint trauma, suppurative arthritis, etc;
- •(3) Knee osteoarthritis caused by osteomyelitis, bone tumor and bone tuberculosis;
- •(4) Patients with pyogenic and nonspecific infectious knee osteoarthritis were found;
- •(5) The patients with advanced joint deformity or disability;
- •(6) Intra articular treatment including intra-articular injection of drugs, intra-articular irrigation and arthroscopic surgery were performed within 3 months before the trial;
- •(7) Patients with multiple lower extremity osteoarthritis of hip, knee and ankle had lower limb pain due to the onset of lumbar degenerative disease;
- •(8) Alt >=1.5 ULN, abnormal Cr contration;
- •(9) Pregnant or lactating women;
- •(10) People with allergic constitution or allergic to this drug;
- •(11) Patients with severe cardiovascular and cerebrovascular diseases, blood system, liver, gastrointestinal tract, kidney disease and diabetes mellitus;
- •(12) Mental patients;
- •(13) Those who have used hormone therapy within one month;
- •(14) Those who have used other drugs for the treatment of knee osteoarthritis within one week before the trial, such as non steroidal anti-inflammatory drugs, benzothiazides, glucosamine, chondroitin sulfate and related traditional Chinese medicine;
- •(15) Long term use of other drugs that affect the efficacy and safety of the trial drug and take comprehensive treatment;
- •(16) Patients who have participated in other clinical trials within three months;
- •(17) The researchers consider that it is not suitable to participate in this experiment.
研究者
相似试验
进行中（未招募）
1 期
A clinical trial where patients with the lung disease autoimmunePulmonary Alveolar Proteinosis will be given the drug molgramostim nebulizer solution byinhalation.Autoimmune Pulmonary Alveolar Proteinosis (aPAP)MedDRA version: 21.1Level: LLTClassification code 10037316Term: Pulmonary alveolar proteinosisSystem Organ Class: 100000004855EUCTR2020-001263-85-ROSavara ApS160
已完成
不适用
Clinical trial of fluoride varnish in preventing dental caries of Sjögren’s syndrome patientsISRCTN85164658Research Grants Council of Hong Kong120
尚未招募
3 期
Clinical study for validating the effectiveness of Tendoease tablet in the rehabilitation of tendonitis.CTRI/2024/03/064125Meyer Organics Pvt Ltd
已完成
3 期
Herbal formulation clinical trial for immune supportCTRI/2020/02/023359Botanic Healthcare Pvt Ltd
招募中
3 期
Once-daily inhaled molgramostim nebulizer solution in aPAP.Autoimmune Pulmonary Alveolar Proteinosis(aPAP)JPRN-jRCT2051210036Desai Dhaval40